Capricor Therapeutics (CAPR) EBITDA Margin (2011 - 2024)
Capricor Therapeutics (CAPR) recorded EBITDA Margin of -65.60% in Q4 2024, down 57.54 percentage points from -8.05% a year earlier but up 493.68 percentage points from the prior quarter.
Powered by 
Analysis
Capricor Therapeutics (CAPR) EBITDA Margin (2011 - 2024) Analysis & Trends
For FY2024, Capricor Therapeutics reported EBITDA Margin of -184.48%, down 93.09 percentage points from FY2023.
- Annual EBITDA Margin has a five-year change of +567.93 percentage points (FY2019 to FY2024).
- Across earlier years, EBITDA Margin came in at -91.39% in FY2023 (+1051.65 pp), -1143.04% in FY2022 (+7306.50 pp), -8449.54% in FY2021 (-4083.35 pp) and -4366.18% in FY2020 (-3613.77 pp).
- Quarterly EBITDA Margin has ranged from -22996.36% in Q3 2020 to -8.05% in Q4 2023 over the past five years.
- On a year-over-year basis, EBITDA Margin has declined for three consecutive quarters, with an average year-over-year change of +94.36 percentage points over the last six quarters.
- Peak year-over-year performance for EBITDA Margin in the last five years was a gain of 4464.09 percentage points in Q2 2021, against a drop of 21880.85 percentage points in Q3 2020 at the low end.
- Per Business Quant, the preceding three quarters came in at -559.27% (Q3 2024), -282.88% (Q2 2024) and -202.46% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,170.64 Bn | 1,139.22 Bn | 19.71 Bn | 53.49% |
| 2 | Johnson & Johnson | 640.54 Bn | 559.06 Bn | 17.26 Bn | 35.95% |
| 3 | AbbVie | 501.78 Bn | 474.89 Bn | 12.70 Bn | 49.01% |
| 4 | Merck | 374.95 Bn | 329.32 Bn | 12.21 Bn | 6.02% |
| 5 | Novartis Ag | 302.43 Bn | 266.42 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 268.31 Bn | 241.99 Bn | 12.86 Bn | 33.11% |
| 7 | Amgen | 242.70 Bn | 198.10 Bn | 7.24 Bn | 46.01% |
| 8 | Gilead Sciences | 193.64 Bn | 167.84 Bn | 6.22 Bn | -124.26% |
| 9 | Pfizer | 172.34 Bn | 118.98 Bn | 10.94 Bn | 39.16% |
| 10 | Capricor Therapeutics | 361.75 Mn | -571.49 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | -65.60% |
| Sep 30, 2024 | -559.27% |
| Jun 30, 2024 | -282.88% |
| Mar 31, 2024 | -202.46% |
| Dec 31, 2023 | -8.05% |
| Sep 30, 2023 | -106.50% |
| Jun 30, 2023 | -191.26% |
| Mar 31, 2023 | -266.33% |
| Dec 31, 2022 | -820.37% |
| Sep 30, 2022 | -398.40% |
| Jun 30, 2021 | -2,465.17% |
| Mar 31, 2021 | -12,521.93% |
| Dec 31, 2020 | -7,156.26% |
| Sep 30, 2020 | -22,996.36% |
| Jun 30, 2020 | -6,929.26% |
| Mar 31, 2020 | -1,117.18% |
| Dec 31, 2019 | -648.65% |
| Sep 30, 2019 | -1,115.51% |
| Jun 30, 2019 | -492.89% |
| Mar 31, 2019 | -1,090.60% |
API Access
Capricor Therapeutics EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CAPR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "CAPR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=CAPR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();